These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32240715)

  • 41. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.
    Gaudy-Graffin C; Lesage G; Kousignian I; Laperche S; Girault A; Dubois F; Goudeau A; Barin F
    J Clin Microbiol; 2010 Sep; 48(9):3281-7. PubMed ID: 20610669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.
    Thomson EC; Nastouli E; Main J; Karayiannis P; Eliahoo J; Muir D; McClure MO
    AIDS; 2009 Jan; 23(1):89-93. PubMed ID: 19050390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Co-infection of hepatitis C virus among newly diagnosed HIV-infected adults in Taizhou prefecture of Zhejiang province, China].
    Zhou L; Wu Q; Shen W; Gao M; Ding Y; Lin H; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):862-6. PubMed ID: 26714544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
    Valencia La Rosa J; Ryan P; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Moreno S
    PLoS One; 2018; 13(10):e0204795. PubMed ID: 30281616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014.
    van Santen DK; van der Helm JJ; Del Amo J; Meyer L; D'Arminio Monforte A; Price M; Béguelin CA; Zangerle R; Sannes M; Porter K; Geskus RB; Prins M;
    J Hepatol; 2017 Aug; 67(2):255-262. PubMed ID: 28412290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.
    Clipman SJ; Mehta SH; Mohapatra S; Srikrishnan AK; Zook KJC; Kumar MS; Lucas GM; Latkin CA; Solomon SS
    J Viral Hepat; 2024 Sep; 31(9):535-543. PubMed ID: 38837275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Macías J; Pineda JA; Lozano F; Corzo JE; Ramos A; León E; García-García JA; Fernández-Rivera J; Mira JA; Gómez-Mateos J
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):675-80. PubMed ID: 14574616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C in a Mobile Low-Threshold Methadone Program.
    Silva MJ; Pereira C; Loureiro R; Balsa C; Lopes P; Água-Doce I; Belo E; Martins HC; Coutinho R; Pádua E
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):657-662. PubMed ID: 28151750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.
    Pérez-Gracia T; Galán F; Fernández-Gutiérrez C; Girón JA; Rodríguez-Iglesias M
    Liver; 1999 Aug; 19(4):288-93. PubMed ID: 10459626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
    Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
    J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
    Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
    Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C virus infection in the mothers and infants cohort study.
    Granovsky MO; Minkoff HL; Tess BH; Waters D; Hatzakis A; Devoid DE; Landesman SH; Rubinstein A; Di Bisceglie AM; Goedert JJ
    Pediatrics; 1998 Aug; 102(2 Pt 1):355-9. PubMed ID: 9685438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.